The Pulse of New York Tech
Gyala Therapeutics is focused on developing new CAR-T therapies for treating hematological malignancies.. Gyala Therapeutics is backed by investors that include Invivo Capital Partners and is headquartered in Barcelona.
WRITE FOR US
NYC TECH EVENTS
NYC TECH NEWS
Join the millions and keep up with the stories shaping entrepreneurship. Sign up today.